Ozone Injection vs ESWT for Chronic Achilles Tendinopathy
Comparison of Ultrasound-Guided Local Ozone Injection and Extracorporeal Shock Wave Therapy in the Treatment of Chronic Achilles Tendinopathy
1 other identifier
interventional
63
1 country
1
Brief Summary
This randomized controlled clinical trial compares ultrasound-guided local ozone injection, extracorporeal shock wave therapy, and conventional conservative treatment in patients with chronic Achilles tendinopathy. The study focuses on changes in pain, functional outcomes, and overall clinical improvement during the follow-up period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 2, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 2, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2026
CompletedFirst Submitted
Initial submission to the registry
February 9, 2026
CompletedFirst Posted
Study publicly available on registry
February 17, 2026
CompletedFebruary 17, 2026
January 1, 2026
8 months
February 9, 2026
February 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Pain intensity (Visual Analog Scale, VAS)
Pain intensity is assessed using the Visual Analog Scale (VAS).
Baseline, post-treatment, and 12 weeks after treatment
Pain intensity assessed by Visual Analog Scale (VAS)
The Visual Analog Scale (VAS) is used to assess subjective pain intensity related to Achilles tendon pain.
Baseline, post-treatment, and 12-week follow-up
Secondary Outcomes (2)
Victorian Institute of Sports Assessment-Achilles (VISA-A) score
Baseline, post-treatment, and 12-week follow-up
Roles and Maudsley Score (RMS)
Baseline, post-treatment, and 12-week follow-up
Study Arms (3)
Ultrasound-Guided Ozone Injection
ACTIVE COMPARATORParticipants receive ultrasound-guided local ozone injection administered to the affected Achilles tendon according to a standardized treatment protocol.
Extracorporeal Shock Wave Therapy (ESWT)
ACTIVE COMPARATORParticipants receive extracorporeal shock wave therapy applied to the affected Achilles tendon according to a standardized treatment protocol.
Conventional Conservative Treatment
OTHERParticipants receive conventional conservative treatment consisting of a standardized exercise program and activity modification.
Interventions
Ultrasound-guided local ozone injection is administered to the peritendinous region of the affected Achilles tendon under sterile conditions using a high-frequency linear transducer, according to a standardized treatment protocol.
Extracorporeal shock wave therapy is applied to the affected Achilles tendon according to a standardized treatment protocol.
Conventional conservative treatment consists of a standardized exercise program and activity modification.
Eligibility Criteria
You may qualify if:
- Patients aged 18 to 65 years.
- Patients with a diagnosis of Achilles tendinopathy confirmed by ultrasonography or magnetic resonance imaging (MRI).
- Patients with persistent symptoms despite completion of conservative treatment.
- Volunteers who agree to participate in the study.
You may not qualify if:
- Patients with symptoms lasting less than 12 weeks.
- Presence of contraindications to extracorporeal shock wave therapy (ESWT), including pregnancy; history of thrombosis; use of anticoagulant medications; coagulation disorders such as hemophilia; systemic conditions; or localized conditions at the treatment site such as active infection or malignant tumors.
- Presence of contraindications to local ozone injection, including pregnancy; glucose-6-phosphate dehydrogenase (G6PD) deficiency; favism; uncontrolled hyperthyroidism; thrombocytopenia; severe cardiovascular conditions; and use of angiotensin-converting enzyme (ACE) inhibitors.
- History of neurological disease, muscle disease, or peripheral vascular disease.
- Presence of congenital or acquired deformities of the knee and/or ankle.
- Receipt of physical therapy modalities applied to the Achilles tendon within the last 6 weeks.
- Receipt of any therapeutic injection to the Achilles tendon within the last 12 weeks.
- History of direct trauma to the symptomatic Achilles tendon or Achilles tendon rupture.
- History of surgical treatment involving the Achilles tendon or ankle for any reason.
- History of foot or ankle dislocation or fracture within the past 1 year.
- Presence of systemic inflammatory diseases that may affect tendon structure, such as ankylosing spondylitis, reactive arthritis, or psoriatic arthritis.
- Patients with isolated insertional Achilles tendinopathy without tenderness in the mid-portion of the tendon
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Bilkent City Hospital - Physical Medicine and Rehabilitation Hospital
Ankara, Cankaya, 06800, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessors are blinded to group allocation. No other parties are masked in this study.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- medical doctor
Study Record Dates
First Submitted
February 9, 2026
First Posted
February 17, 2026
Study Start
May 2, 2025
Primary Completion
January 2, 2026
Study Completion
January 15, 2026
Last Updated
February 17, 2026
Record last verified: 2026-01